Journal for ImmunoTherapy of Cancer (Nov 2020)

438 Synergy between SEA-CD40 and chemotherapeutics drives curative antitumor activity in preclinical models

  • Michael Schmitt,
  • Weiping Zeng,
  • Celine Jacquemont,
  • Haley Neff-LaFord,
  • Sahar Ansari

DOI
https://doi.org/10.1136/jitc-2020-SITC2020.0438
Journal volume & issue
Vol. 8, no. Suppl 3

Abstract

Read online

No abstracts available.